Skip to content

To determine the Glycemic Index & Glycemic response of test products.

A Randomized, Open Label, Cross Over, Single Centric, Accessor Blinded, Clinical Study to determine the Glycemic Index & Glycemic response of test products in Healthy Indian Adult Participants. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/101454
Enrollment
20
Registered
2026-01-19
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Viemax Diabetes Care (Kesar Badam): 25 g available carbohydrates providing test product will be served with 300 ml water. Single Consumption. Intervention2: Viemax Diabetes Care (Vanill

Sponsors

Zydus Wellness Products Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Participants having fasting blood glucose levels less than 100 mg/dL. 2) Participants having HbA1c level less than 5.7 percentage. 3) Participants with Body Mass Index of 18.5 to 22.9 kg/m2 (both inclusive). 4) Participants who can understand and provide written informed consent to participate in the study. 5) Participants who are willing to refrain from vigorous physical exercise during the study period.

Exclusion criteria

Exclusion criteria: 1) Participants with any known food allergy or intolerance to any food or beverages. 2) Participants who are taking any medication for past one week including home remedies for diabetes or ayurvedic medications or any plant extracts. 3) Pre-diabetic participants with HbA1c level of 5.7% to 6.4% and diabetic participants with HbA1c level of 6.5% or higher. 4) Participants with recent history of dehydration from diarrhoea, vomiting or any other reason within a period of 24 hours prior to the study. 5) Participants who have participated in any clinical trial within the past 90 days with blood loss more than 450 ml. 6) Participants who are on an unusual diet, special diet, for whatever reason e.g., high protein diet, low sodium diet, for two weeks prior to receiving any reference/test product and throughout subject s participation in the study. 7) Participants having history of Hepatitis B or C virus.

Design outcomes

Primary

MeasureTime frame
1) To determine the glycemic index of test product, in healthy participants. 2) To determine the glycemic response (when consumed with milk) of test product, in healthy participants.Timepoint: 05 mins prior to product administration and 0, 15, 30, 45, 60, 90 and 120 minutes post product administration on each product administration day.

Secondary

MeasureTime frame
Assessment of Satiety level (in terms of feeling of hunger, fullness, satisfaction and desire to eat) using Visual Analogue Scale (VAS)Timepoint: 5 mins prior to product administration and 15, 30, 60, 90 and 120 minutes post product administration on each product administration day.

Countries

India

Contacts

Public ContactDr Parth Joshi

Cliantha Research

damori@cliantha.com9773262487

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026